Pulmonary emboli in sclerotherapy for peripheral vascular malformations under general anesthesia; A report of two cases

Japanese Journal of Anesthesiology

Volumn 53, Issue 6, 2004, Pages 645-649

  Tachibana, Kaori ^a   Kobayashi, Shigeaki ^a   Kojima, Taku ^a   Kaseno, Shigeo ^a   Kemmotsu, Osamu ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Complication; General anesthesia; Pulmonary embolism; Sclerotherapy; Vascular malformations

Indexed keywords

ALCOHOL; HEPARIN; POLIDOCANOL; UROKINASE;

ADOLESCENT; ANESTHETIC RECOVERY; ARTICLE; CASE REPORT; CASE STUDY; CONGENITAL BLOOD VESSEL MALFORMATION; FEMALE; GENERAL ANESTHESIA; HEMOGLOBINURIA; HUMAN; HYPOCAPNIA; HYPOXIA; LUNG EMBOLISM; LUNG SCINTISCANNING; MALE; PATIENT MONITORING; PERIPHERAL VASCULAR DISEASE; POSTOPERATIVE COMPLICATION; SCLEROTHERAPY; SHIVERING;

ADOLESCENT; ANESTHESIA, GENERAL; ETHANOL; FEMALE; HEMOGLOBINURIA; HEPARIN; HUMANS; LEG; MALE; POLYETHYLENE GLYCOLS; PULMONARY EMBOLISM; SCLEROTHERAPY; TREATMENT OUTCOME; URINARY PLASMINOGEN ACTIVATOR; VEINS;

EID: 3142556103     PISSN: 00214892     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Lee BB, Kim DI, Huh S, Kim HH, Choo IW, Byun HS, et al. New experiences with absolute ethanol sclerotherapy in the management of a complex form of congenital venous malformation. J Vasc Surg 2001; 33: 764-72.
2. Hanafi M, Orliaguet G, Meyer P, Blanot S, Brunelle F, Carli P. Pulmonary embolism in sclerotherapy for a venous malformation in a child under general anesthesia. Ann Fr Anesth Reanim 2001; 20: 556-8.
3. Brunken C, Topp S, Tesch C, Druge G, Malago M, Meiners J, et al. Systemic effects and side effects of interstitial techniques used in liver tissue. J Am Coll Surg 1999; 188: 636-42.
4. Yakes WF, Krauth L, Ecklund J, Swengle R, Dreisbach JN, Seibert CE, et al. Ethanol endovascular management of brain arteriovenous malformations: initial results. Neurosurgery 1997; 40: 1145-52.
5. Lee BB, Bergan JJ. Advanced management of congenital vascular malformations: a multidisciplinary approach. Cardiovasc Surg 2002; 10: 523-33.
6. Stricker BH, van Oijen JA, Kroon C, Ovink AH. Anaphylaxis following use of polidocanol. Ned Tijdschr Geneeskd 1990; 134: 240-2.
7. Marrocco-Trischitta MM, Guerrini P, Abeni D, Stillo F. Reversible cardiac arrest after polidocanol sclerotherapy of peripheral venous malformation. Dermatol Surg 2002; 28: 153-5.
8. Conrad P, Malouf GM, Stacy MC. The Australian polidocanol (a ethoxyskelerol) study. Dermatol Surg 1995; 21: 334-6.
9. Feied CF. The risk of scleraotherapy in hypercoagulable states. Semin Dermatol 1993; 12: 135-49.
10. Frullini A, Cavezzi A. Sclerosing foam in the treatment of varicose veins and telangiectases: history and analysis of safety and complications. Dermatol Surg 2002; 28: 11-5.
11. Yamaki T, Nozaki M, Sasaki K, Color duplex-guided sclerotherapy for the treatment of venous malformations. Dermatol Surg 2000; 26: 323-8.
12. Marrocco-trischitta MM, Nicodemi EM, Stillo F. Sclerotherapy for venous malformations of the glans penis. Urology 2001; 57: 310-3.
13. Ikeda M, Kambayashi J, Iwamoto S. Hemostasis activation during sclerotherapy of lower extremity varices. Thromb Res 1996; 82: 87-95.